Page 10685
Dec 5, 2016
Fight Aging predicts the sequence of arrival for meaningful antiaging therapies
Posted by Steve Hill in categories: biotech/medical, life extension
The full antiaging rejuvenation toolkit of the next few decades will consist of a range of different treatments, each targeting a different type of molecular damage in cells and tissues. Fightaging predicts the likely order of arrival of some of these therapies, based on what is presently going on in research, funding, and for-profit development.
1) Clearance of Senescent Cells
Everon Biosciences, Oisin Biotechnologies, SIWA Therapeutics, and UNITY Biotechnology are all forging ahead with various different approaches to the selective destruction of senescent cells. No doubt many groups within established Big Pharma entities are also taking a stab at this, more quietly, and with less press attention. UNITY Biotechnology has raised more than $100 million to date, demonstrating that there is broad enthusiasm for this approach to the treatment of aging and age-related disease.
Continue reading “Fight Aging predicts the sequence of arrival for meaningful antiaging therapies” »
Dec 5, 2016
17 for ‘17: Microsoft researchers on what to expect in 2017 and 2027
Posted by Klaus Baldauf in categories: business, computing, education
This week we are celebrating Computer Science Education Week around the globe.
In this “age of acceleration,” in which advances in technology and the globalization of business are transforming entire industries and society itself, it’s more critical than ever for everyone to be digitally literate, especially our kids.
This is particularly true for women and girls who, while representing roughly 50 percent of the world’s population, account for less than 20 percent of computer science graduates in 34 OECD countries, according to this report.
Continue reading “17 for ‘17: Microsoft researchers on what to expect in 2017 and 2027” »
Dec 5, 2016
European VCs are going to make flying cars a reality
Posted by Klaus Baldauf in categories: futurism, transportation
Planting a flag in Europe for the development of the kind of “deep technology” companies that have long been the bread and butter of Silicon Valley, the European venture firm Atomico has invested 10 million euros in the vertical take-off and landing plane developer, Lilium Aviation.
The roughly $10.7 million Series A investment announced at TechCrunch Disrupt London is meant to help Lilium develop into a manufacturer of a commuter alternative to helicopters and traditional planes.
Since the 1950s and 1960s, flying cars have ranked right up there with jetpacks as an example of the fulfillment of our expectations for future travel (I still think the Uber and Lyft app is pretty magical).
Continue reading “European VCs are going to make flying cars a reality” »
Please support SENS Research on Amazon Smile this Christmas smile
Dont forget you can help SENS Research Foundation even during your Christmas shopping this year! Using Amazon Smile you can buy your gifts in the normal way but Amazon will donate 0.5% of the price of your eligible AmazonSmile purchases to us whenever you shop on AmazonSmile. bigsmile
#aging #sens
The SENS Research Foundation are proudly fostering the future of scientific studies though their Summer Scholars Program.
Learn about the annual SRF Summer Scholars program from some of our alumni and faculty mentors.
Dec 5, 2016
‘Westworld’ Season 2: When Does the Show Return?
Posted by Shailesh Prasad in category: entertainment
When does Westworld return for season 2? (HBO)
Westworld has been a wonderful show with intricate layers-upon-layers. It seems destined to be the next Game of Thrones for HBO and could reach the level of popularity that Lost enjoyed. J.J. Abrams definitely has another hit on his hands. But now that the first season has ended far too soon, when does the second season begin? Unfortunately, it will likely be farther away than you’re hoping.
First, the good news. Westworld has indeed been renewed for a second season. Season 2 will run for 10 episodes, just like Season 1, according to EW.
Continue reading “‘Westworld’ Season 2: When Does the Show Return?” »
Dec 5, 2016
The 10 Algorithms Machine Learning Engineers Need to Know
Posted by Elmar Arunov in categories: entertainment, information science, robotics/AI
Read this introductory list of contemporary machine learning algorithms of importance that every engineer should understand.
By James Le, New Story Charity.
Continue reading “The 10 Algorithms Machine Learning Engineers Need to Know” »
Dec 4, 2016
Breakthrough prize awards $25m to researchers at ‘Oscars of science’
Posted by Shane Hinshaw in categories: bioengineering, information science, quantum physics, science
It is not often that a scientist walks the red carpet at a Silicon Valley party and has Morgan Freeman award them millions of dollars while Alicia Keys performs on stage and other A-listers rub shoulders with NASA astronauts.
But the guest list for the Breakthrough prize ceremony is intended to make it an occasion. At the fifth such event in California last night, a handful of the world’s top researchers left their labs behind for the limelight. Honoured for their work on black holes and string theory, DNA repair and rare diseases, and unfathomable modifications to Schrödinger’s equation, they went home to newly recharged bank accounts.
Founded by Yuri Milner, the billionaire tech investor, with Facebook’s Mark Zuckerberg and Google’s Sergey Brin, the Breakthrough prizes aim to right a perceived wrong: that scientists and engineers are not appreciated by society. With lucrative prizes and a lavish party dubbed “the Oscars of science”, Milner and his companions want to elevate scientists to rock star status.
Continue reading “Breakthrough prize awards $25m to researchers at ‘Oscars of science’” »
Dec 4, 2016
A First-of-Its-Kind HIV Vaccine Will Move to Phase II Trials in 2017
Posted by Bryan Gatton in category: biotech/medical
A brand new type of HIV vaccine will move onto phase II clinical trials in 2017, after phase I trials showed that it was safe to use in humans.
The potential new vaccine will be tested on 600 people in North America, to see how well it can prevent them from getting the virus.
Before we get too excited, the phase I trials were only set up to show that the vaccine was tolerated well by the human body — they didn’t demonstrate if it actually works as a preventative treatment.
Continue reading “A First-of-Its-Kind HIV Vaccine Will Move to Phase II Trials in 2017” »